John Frater

25.0k total citations
100 papers, 2.9k citations indexed

About

John Frater is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, John Frater has authored 100 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Virology, 51 papers in Infectious Diseases and 39 papers in Immunology. Recurrent topics in John Frater's work include HIV Research and Treatment (75 papers), HIV/AIDS Research and Interventions (38 papers) and HIV/AIDS drug development and treatment (37 papers). John Frater is often cited by papers focused on HIV Research and Treatment (75 papers), HIV/AIDS Research and Interventions (38 papers) and HIV/AIDS drug development and treatment (37 papers). John Frater collaborates with scholars based in United Kingdom, United States and South Africa. John Frater's co-authors include Sarah Fidler, Jonathan Weber, James P. Williams, Rodney E. Phillips, Myra O. McClure, Jacob Hurst, Rodney Phillips, Paul Klenerman, Nicola Robinson and Matthew Pace and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature reviews. Immunology.

In The Last Decade

John Frater

95 papers receiving 2.8k citations

Peers

Countries citing papers authored by John Frater

Since Specialization

Citations

This map shows the geographic impact of John Frater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Frater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Frater more than expected).

Fields of papers citing papers by John Frater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Frater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Frater. The network helps show where John Frater may publish in the future.

Co-authorship network of co-authors of John Frater

This figure shows the co-authorship network connecting the top 25 collaborators of John Frater. A scholar is included among the top collaborators of John Frater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Frater. John Frater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of antiretroviral therapy during primary HIV infection on T‐cell immunity after treatment interruption 2024 ·European Journal of Immunology ·Timothy Tipoe, Ane Ogbe, Ming Lee, Helen Brown, Nicola Robinson, (unknown), Claire Petersen, (unknown), John Thornhill, Fiona Ryan, Julie Fox, Sarah Fidler, John Frater	1
2	Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning 2024 ·PLoS Computational Biology ·(unknown), Panagiota Zacharopoulou, Robert Hinch, Chris Wymant, Lucie Abeler‐Dörner, John Frater, Christophe Fraser	2
3	Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination 2024 ·Frontiers in Immunology ·(unknown), John Frater	3
4	Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound 2022 ·Scientific Reports ·Panagiota Zacharopoulou, Emanuele Marchi, Ane Ogbe, Nicola Robinson, Helen Brown, Mathew Jones, Lucia Parolini, Matthew Pace, Nicholas Grayson, Pontiano Kaleebu, Helen Rees, Sarah Fidler, Philip Goulder, Paul Klenerman, John Frater	8
5	HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper 2020 ·Journal of Virus Eradication ·Sarah Fidler, Sharon R. Lewin, Steven G. Deeks, Ole S. Søgaard, Linos Vandekerckhove, Simon Collins, Dominic F. Kelly, Jerome Amir Singh, Marina Caskey, John Frater	8
6	Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion 2019 ·The Journal of Infectious Diseases ·Geneviève Martin, Matthew Pace, Freya M. Shearer, (unknown), Jacob Hurst, Jodi Meyerowitz, John Thornhill, Julianne Lwanga, Helen Brown, Nicola Robinson, Emily Hopkins, Natalia Olejniczak, Nneka Nwokolo, Julie Fox, Sarah Fidler, Christian B. Willberg, John Frater	18
7	Maintenance of Functional CD57+Cytolytic CD4+T Cells in HIV plus Elite Controllers 2019 ·Frontiers in Immunology ·Chansavath Phetsouphanh, Daniel L. Aldridge, Emanuele Marchi, (unknown), Jodi Meyerowitz, Lesley Murray, Cloete van Vuuren, Dominique Goedhals, Sarah Fidler, Anthony D. Kelleher, Paul Klenerman, John Frater	0
8	Sustained HIV-1 remission following CCR5D32/D32 allogeneic haematopoietic stem cell transplantation 2019 ·HIV Medicine ·Rakesh Gupta, Sultan Abdul-Jawad, Laura E. McCoy, Dimitra Peppa, María Salgado, Javier Martínez‐Picado, A. M. J. Wensing, Monique Nijhuis, Hoi Ping Mok, Eleni Nastouli, Matthew Pace, John Frater, Laura Waters, (unknown), Andrew Lever, Ian Gabriel, (unknown)	2
9	CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype 2019 ·Mucosal Immunology ·John Thornhill, Matthew Pace, Geneviève Martin, Jonathan Hoare, S. Peake, Carolina Herrera, Chansavath Phetsouphanh, Jodi Meyerowitz, Emily Hopkins, Helen Brown, (unknown), Natalia Olejniczak, Christian B. Willberg, Paul Klenerman, Robert Goldin, Julie Fox, Sarah Fidler, John Frater	17
10	Virological remission after antiretroviral therapy interruption in female African HIV seroconverters 2018 ·AIDS ·Morgane Gossez, Geneviève Martin, Matthew Pace, Gita Ramjee, (unknown), Pontiano Kaleebu, Helen Rees, Jamie Inshaw, Wolfgang Stöhr, Jodi Meyerowitz, Emily Hopkins, Mathew Jones, Jacob Hurst, Kholoud Porter, Abdel Babiker, Sarah Fidler, John Frater	10
11	Engineered affinity-enhanced immune-mobilising monoclonal T cell receptors (ImmTAVs) for HIV cure 2017 ·HIV Medicine ·(unknown), Hongli Yang, Jakub Chojnacki, John Frater, Lucy Dorrell, Sarah Fidler, (unknown), Bent K. Jakobsen, (unknown), Giovanna Bossi, Rebecca Ashfield, Annelise Vuidepot, (unknown), Peter Molloy, J Oates, Samantha Paston, (unknown)	1
12	Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection 2017 ·AIDS ·Geneviève Martin, Morgane Gossez, James P. Williams, Wolfgang Stöhr, Jodi Meyerowitz, Ellen M. Leitman, Philip Goulder, Kholoud Porter, Sarah Fidler, John Frater	40
13	The effect of Maraviroc intensification on gut reservoir and immune function in HIV-1-infected individuals receiving antiretroviral therapy with suboptimal CD4+T cell recovery 2016 ·HIV Medicine ·Juan Tiraboschi, Julie Fox, Stuart C. Ray, Joseph P. Sanderson, John Frater, Nicola Robinson, Matthew Pace, Jodi Meyerowitz, Sarah Fidler	1
14	Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir 2016 ·AIDS Research and Human Retroviruses ·Juan Tiraboschi, Shuvra Ray, (unknown), Matthew Pace, Prabhjeet Phalora, Nicola Robinson, Emily Hopkins, Jodi Meyerowitz, Yanzhong Wang, (unknown), Christine Mant, John Cason, Steve Kaye, Jeremy Sanderson, Sarah Fidler, Paul Klenerman, John Frater, Julie Fox	6
15	Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection 2016 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Sarah Fidler, Ashley Olson, Heiner C. Bucher, Julie Fox, John Thornhill, Charles Morrison, Roberto Muga, Andrew Phillips, John Frater, Kholoud Porter	24
16	Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence 2014 ·Proceedings of the National Academy of Sciences ·Rebecca Payne, Maximilian Muenchhoff, Jaclyn K. Mann, Hannah Roberts, Philippa C. Matthews, Emily Adland, (unknown), Kuan‐Hsiang Gary Huang, Mark A. Brockman, Zabrina L. Brumme, Marc Sinclair, Toshiyuki Miura, John Frater, Max Essex, Roger Shapiro, Bruce D. Walker, Thumbi Ndung’u, Angela R. McLean, Jonathan M. Carlson, Philip Goulder	62
17	Longitudinal analysis of an HLA-B51-restricted epitope in integrase reveals immune escape in early HIV-1 infection 2012 ·AIDS* ·Nicole Yager, Nicola Robinson, Helen Brown, Peter R. Flanagan, John Frater, Sarah Fidler, (unknown), (unknown)	3
18	Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations 2011 ·PLoS ONE ·Kuan‐Hsiang Gary Huang, Dominique Goedhals, Jonathan M. Carlson, Mark A. Brockman, Swati Mishra, Zabrina L. Brumme, (unknown), Christopher S. Tang, Toshiyuki Miura, Christopher J. Seebregts, David Heckerman, Thumbi Ndung’u, Bruce D. Walker, Paul Klenerman, Dewald Steyn, Philip Goulder, Rodney Phillips, (unknown), Cloete van Vuuren, John Frater	45
19	Protective HLA class I alleles are associated with reduced immune activation and fibrinolysis in individuals with primary HIV infection 2010 ·UCL Discovery (University College London) ·Elizabeth Hamlyn, (unknown), John Frater, (unknown), Ahmed Babiker, Myra O. McClure, Sarah Fidler	0
20	Performance of two commercially available sequence‐based HIV‐1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes 2003 ·Journal of Medical Virology ·Simon Beddows, S. Galpin, (unknown), (unknown), Ayman Johargy, John Frater, (unknown), (unknown), John Clarke, Myra O. McClure, Jonathan Weber	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact